Podcast
 |
| Jerry Flanagan, healthcare policy director for ConsumerWatchdog, discusses his group’s lawsuit against Anthem Blue Cross of California over its rate hikes, what they mean for healthcare reform, and why the proposed healthcare legislation wouldn’t have prevented Anthem from instituting the rate increases in the first place. |
G. Steven Burrill
Welcome from the CEO
Flash required to view this video. Download the latest version here
G. Steven BurrillNews
Biotech posts gain in February as broader markets strengthen March 03, 2010 | Press Release
Biotech holds steady in January as broader markets head south February 01, 2010 | Press Release
Biotech Closes the Year on an Upswing January 04, 2010 | Press Release
See all News
Burrill Media is the creator, sponsor and facilitator of over a dozen leading industry conferences worldwide and publishes a wide range of bio-intelligence reports. Annual conferences include The Biotech Meeting, The Indiana Life Sciences Forum, The Burrill Personalized Medicine Meeting, The Aging Meeting and The Stem Cell Meeting. Burrill Media publications include the annual State of the Industry, The Personalized Medicine Report, The Stem Cell Report, and periodic newsletters covering Canada, China, Europe, India, Japan and Partnering/M&A. Burrill also publishes The Burrill Report, a monthly digital publication.
Biotech 2008: A 20/20 Vision To 2020 (Online)
The publication includes:
- Biotech in 2020
- 2007 Industry Financials, including 12 months of company financial data and market caps for the US, Europe, Canada, and Asia
- Analysis of key activities across industry sectors including healthcare, personalized, predictive and, preventive medicine, wellness, ag-biotech, industrial biotechnology and biofuels
- Highlights of the most important recent advances in technology including stem cells and nanotechnology
- Politics and Policy - with special features on the presidential campaign and how it is likely to affect the life sciences industry
- Analysis of deal making, the venture capital environment and capital markets.
- The biotech industry around the world - Canada, Europe, Asia, with special features on emerging global players such as China, India, Malaysia, Brazil
Download the executive summary
Add to cart$295.00